Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats
2000 ◽
Vol 87
(6)
◽
pp. 829-837
◽
2001 ◽
Vol 97
(1)
◽
pp. 115-120
◽
2006 ◽
Vol 14
(1)
◽
pp. 230-238
◽
1997 ◽
Vol 24
(2-3)
◽
pp. 245-256
◽
2006 ◽
Vol 12
(1)
◽
pp. 175-182
◽
1990 ◽
Vol 125
(2)
◽
pp. 220
◽